Bridgepoint Group plc (LON:BPT – Get Free Report)’s share price traded down 11.6% during trading on Tuesday . The stock traded as low as GBX 247.20 ($3.15) and last traded at GBX 247.80 ($3.15). 97,968,586 shares were traded during mid-day trading, an increase of 1,929% from the average session volume of 4,828,735 shares. The stock had previously closed at GBX 280.40 ($3.57).
Wall Street Analysts Forecast Growth
Separately, Citigroup upgraded Bridgepoint Group to a “buy” rating and set a GBX 410 ($5.22) target price for the company in a research note on Thursday, March 20th.
View Our Latest Stock Analysis on Bridgepoint Group
Bridgepoint Group Trading Up 3.2 %
Bridgepoint Group (LON:BPT – Get Free Report) last released its quarterly earnings results on Thursday, March 13th. The company reported GBX 19.50 ($0.25) EPS for the quarter. Bridgepoint Group had a net margin of 16.74% and a return on equity of 6.10%. As a group, analysts expect that Bridgepoint Group plc will post 17.4062165 EPS for the current year.
Bridgepoint Group Dividend Announcement
The firm also recently declared a dividend, which will be paid on Thursday, May 22nd. Stockholders of record on Thursday, April 24th will be given a dividend of GBX 4.60 ($0.06) per share. This represents a dividend yield of 1.43%. The ex-dividend date of this dividend is Thursday, April 24th. Bridgepoint Group’s dividend payout ratio is 163.50%.
Bridgepoint Group Company Profile
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Articles
- Five stocks we like better than Bridgepoint Group
- Ride Out The Recession With These Dividend Kings
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- PayPal Stock: Too Cheap to Ignore, Too Strong to Miss
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Progress Software: Making Progress Driven by the AI Revolution
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.